For instance, Dale et al [33] reported that VEGFR-1 was weakly expressed in breast cancer specimens, while Schmidt et al [23] found that VEGFR-1 was expressed in 39% of breast cancer specimens, predominantly in the cytoplasm. This evidence concerns the gene FLT1 and breast cancer.